Image-01 (Image 01)
Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-7319
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-7319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image-02 (Image 02)
This text appears to be related to the evaluation of drug metabolism in special populations, specifically focusing on hepatocellular impairment, renal impairment, CYP2D6 polymorphism, age (especially >80 years), and gender differences. It includes information on various analytes (e.g., venlafaxine) and their monitoring. The text also mentions fold change, 90% confidence interval, and change relative to reference values. This information can be valuable in understanding the pharmacokinetics and dosing considerations in different patient populations.*
Image-03 (Image 03)
This -generated text provides information on changes in drug levels for different analytes when interacting with other drugs or compounds. It includes data on fold changes in pharmacokinetics (PK) along with confidence intervals. The text lists various drug combinations and their effects on maximum concentration (Cmax) and area under the curve (AUC), along with comparisons to reference values. This data can be used to analyze the impact of drug interactions on the pharmacokinetics of the listed substances.*
Image-04 (Image 04)
This text appears to be a list of interacting drugs and analytes, including substances like Ethanol, Diazepam, Alprazolam, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium. The list also mentions different forms or metabolites of these substances. Additionally, there is mention of fold change and 90% confidence interval in relation to a reference value. It seems to be a record of drug interactions and analysis data.*
Label Image (Lbl500907319)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
